[ET Net News Agency, 2 May 2024] FRONTAGE (01521) rose 11.4% to HK$1.37, breaking above
the 20-D SMA of HK$1.345.
It hits an intra-day high of HK$1.37, and an intra-day low of HK$1.21. The total shares
traded was 538,000, with a value of HK$698,660. The active buy/sell ratio is 52:48, with
net buying turnover of HK$22,900. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$66,288, with volume weighted average price of HK$1.307.
FUTU SEC INT'L accounts for greatest net responsive selling turnover of HK$133,480, with
volume weighted average price of HK$1.326.
Basic Information
=================
-----------------------------------
Nominal 1.370 % Chg +11.38%
High 1.370 Low 1.210
Shares Tr 538,000 Turnover 698,660
10-D SMA 1.298 %H.V 40.139
20-D SMA 1.345 VWAP 1.299
50-D SMA 1.503 RSI14 48.727
-----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 52:48, with net buying
turnover of HK$22,900
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
FRONTAGE (01521) 1.37 +11.38
HUTCHMED (00013) 30.85 +1.98
GENSCRIPT BIO (01548) 12.24 +5.15
INNOVENT BIO (01801) 41.65 +8.89
WUXI BIO (02269) 14.50 +5.53
BEIGENE (06160) 97.40 +2.96
SCICLONE PHARMA (06600) 18.00 +0.33
ZAI LAB (09688) 13.52 +4.00
AKESO (09926) 49.00 +1.77
REMEGEN (09995) 30.10 +7.69
-----------------------------------------------
(ed)